CardioKinetix Secures $14.5 Million

CardioKinetix Inc., a Redwood City, Calif.-based heart failure treatment company, secured $14.5 million in Series C funding led by Cutlass Capital, JPMorgan Partners and U.S. Venture Partners, according to VentureWire. Hambrecht & Quist Capital Management participated. Company Web site